Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy, 2014
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy, 2014
Authors
Keywords
-
Journal
INTERNAL MEDICINE JOURNAL
Volume 44, Issue 12b, Pages 1364-1388
Publisher
Wiley
Online
2014-12-08
DOI
10.1111/imj.12600
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Drug interactions: Fatal rhabdomyolysis following voriconazole and simvastatin
- (2016) Elizabeth Doran et al. Australian Prescriber
- Rhabdomyolysis Induced by Simvastatin-Fluconazole Combination
- (2016) Ribhi Hazin et al. JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION
- Clinically relevant drug–drug interactions between antiretrovirals and antifungals
- (2014) Ramya Krishna Vadlapatla et al. Expert Opinion on Drug Metabolism & Toxicology
- DisseminatedScedosporium prolificansinfection in an ‘extensive metaboliser’: navigating the minefield of drug interactions and pharmacogenomics
- (2014) J. A. Trubiano et al. MYCOSES
- A Case-report of Unpredictable and Massive Voriconazole Intoxication in a Patient with Extensive CYP2C19 and CYP2C9 Polymorphisms
- (2013) Florian Lemaitre et al. Drug Metabolism and Pharmacokinetics
- Cardiac toxicity of some echinocandin antifungals
- (2013) Kayla R Stover et al. Expert Opinion On Drug Safety
- Steady-state pharmacokinetics and metabolism of voriconazole in patients
- (2013) M. J. P. Geist et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology
- (2013) H. R. Ashbee et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- A severe case of haemodynamic instability during anidulafungin administration
- (2013) M. Fink et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Cardiac effects of echinocandin preparations - three case reports
- (2013) C. Lichtenstern et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Correlation of CYP2C19 Phenotype With Voriconazole Plasma Concentration in Children
- (2013) Atsushi Narita et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Initial voriconazole trough blood levels and clinical outcomes of invasive aspergillosis in patients with hematologic malignancies
- (2013) Yeon-Joo Lee et al. MEDICAL MYCOLOGY
- Posaconazole Therapeutic Drug Monitoring in the Real-life Setting: A Single-Center Experience and Review of the Literature
- (2013) Barbara N. Gross et al. PHARMACOTHERAPY
- Pharmacokinetics of Different Dosing Strategies of Oral Posaconazole in Patients with Compromised Gastrointestinal Function and Who Are at High Risk for Invasive Fungal Infection
- (2012) Oliver A. Cornely et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Effect of Combined Fluoroquinolone and Azole Use on QT Prolongation in Hematology Patients
- (2012) John D. Zeuli et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Utilization of Omeprazole To Augment Subtherapeutic Voriconazole Concentrations for Treatment of Aspergillus Infections
- (2012) Natalie K. Boyd et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Therapeutic Drug Monitoring of Posaconazole in Allogeneic Hematopoietic Stem Cell Transplantation Patients Who Develop Gastrointestinal Graft-versus-Host Disease
- (2012) J. Tonini et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Therapeutic Drug Monitoring of Posaconazole in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome
- (2012) M. Vaes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multicenter Study of Posaconazole Therapeutic Drug Monitoring: Exposure-Response Relationship and Factors Affecting Concentration
- (2012) Michael J. Dolton et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Single-Dose Phase I Study To Evaluate the Pharmacokinetics of Posaconazole in New Tablet and Capsule Formulations Relative to Oral Suspension
- (2012) Gopal Krishna et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multicenter Study of Voriconazole Pharmacokinetics and Therapeutic Drug Monitoring
- (2012) Michael J. Dolton et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Safety of Posaconazole and Sirolimus Coadministration in Allogeneic Hematopoietic Stem Cell Transplants
- (2012) David W. Kubiak et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Reversible skeletal disease and high fluoride serum levels in hematologic patients receiving voriconazole
- (2012) B. Gerber et al. BLOOD
- Ontogeny and Sorafenib Metabolism
- (2012) E. I. Zimmerman et al. CLINICAL CANCER RESEARCH
- The Effect of Therapeutic Drug Monitoring on Safety and Efficacy of Voriconazole in Invasive Fungal Infections: A Randomized Controlled Trial
- (2012) Wan Beom Park et al. CLINICAL INFECTIOUS DISEASES
- Variable magnitude of drug interaction between oral voriconazole and cyclosporine A in recipients of allogeneic hematopoietic stem cell transplantation
- (2012) Taku Kikuchi et al. CLINICAL TRANSPLANTATION
- Impact of benzodiazepines on posaconazole serum concentrations. A population-based pharmacokinetic study on drug interaction
- (2012) Werner J. Heinz et al. CURRENT MEDICAL RESEARCH AND OPINION
- Switching from intravenous to oral tacrolimus and voriconazole leads to a more pronounced drug–drug interaction
- (2012) Isabel Spriet et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Factors influencing the pharmacokinetics of prophylactic posaconazole oral suspension in patients with acute myeloid leukemia or myelodysplastic syndrome
- (2012) J. J. Vehreschild et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Testing for variants in CYP2C19: population frequencies and testing experience in a clinical laboratory
- (2012) Charles M. Strom et al. GENETICS IN MEDICINE
- Posaconazole plasma concentrations and invasive mould infections in patients with haematological malignancies
- (2012) Martin Hoenigl et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Drug interaction between voriconazole and tacrolimus and its association with the bioavailability of oral voriconazole in recipients of allogeneic hematopoietic stem cell transplantation
- (2012) Takehiko Mori et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Multifocal Nodular Periostitis Associated With Prolonged Voriconazole Therapy in a Lung Transplant Recipient
- (2012) Asad Ayub et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- Investigation and threshold of optimum blood concentration of voriconazole: a descriptive statistical meta-analysis
- (2012) Yukihiro Hamada et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Monitoring trough voriconazole plasma concentrations in haematological patients: real life multicentre experience
- (2012) Zdenek Racil et al. MYCOSES
- Pharmacogenetics and beyond: variability of voriconazole plasma levels in a patient with primary immunodeficiency
- (2012) Julie Autmizguine et al. PHARMACOGENOMICS
- Posaconazole Treatment in Hematology Patients
- (2012) Marie-Rose B. S. Crombag et al. THERAPEUTIC DRUG MONITORING
- Posaconazole Serum Level on Day 2 Predicts Steady State Posaconazole Serum Level
- (2012) Myke R Green et al. THERAPEUTIC DRUG MONITORING
- Comparison of Pharmacokinetics and Safety of Voriconazole Intravenous-to-Oral Switch in Immunocompromised Adolescents and Healthy Adults
- (2011) Timothy A. Driscoll et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Has the era of individualised medicine arrived for antifungals? A review of antifungal pharmacogenomics
- (2011) H R Ashbee et al. BONE MARROW TRANSPLANTATION
- Drug interaction of (S)-warfarin, and not (R)-warfarin, with itraconazole in a hematopoietic stem cell transplant recipient
- (2011) Masatomo Miura et al. CLINICA CHIMICA ACTA
- Fluoride Excess and Periostitis in Transplant Patients Receiving Long-Term Voriconazole Therapy
- (2011) R. A. Wermers et al. CLINICAL INFECTIOUS DISEASES
- A Case of Periostitis Secondary to Voriconazole Therapy in a Heart Transplant Recipient
- (2011) Steven M. Wise et al. CLINICAL NUCLEAR MEDICINE
- Lack of Evidence for Exposure–Response Relationship in the Use of Posaconazole as Prophylaxis Against Invasive Fungal Infections
- (2011) O A Cornely et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Therapeutic drug monitoring of posaconazole in hematology adults under posaconazole prophylaxis: influence of food intake
- (2011) C. Eiden et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Effect of posaconazole on the pharmacokinetics of simvastatin and midazolam in healthy volunteers
- (2011) Gopal Krishna et al. Expert Opinion on Drug Metabolism & Toxicology
- A post-marketing evaluation of posaconazole plasma concentrations in neutropenic patients with haematological malignancy receiving posaconazole prophylaxis
- (2011) Alexander M. Bryant et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Highly activated oral bioavailability of tacrolimus on coadministration of oral voriconazole
- (2011) Y. Inoue et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Flash pulmonary oedema during anidulafungin administration
- (2011) C. B. Hindahl et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Adverse interactions between antifungal azoles and vincristine: review and analysis of cases
- (2011) Brad Moriyama et al. MYCOSES
- Pharmacokinetics of sulfobutylether- -cyclodextrin (SBECD) in subjects on hemodialysis
- (2011) D. R. Luke et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Pharmacogenomics of the triazole antifungal agent voriconazole
- (2011) Gerd Mikus et al. PHARMACOGENOMICS
- Therapeutic Drug Monitoring of Voriconazole and Posaconazole
- (2011) Trana Hussaini et al. PHARMACOTHERAPY
- Modulators of Very Low Voriconazole Concentrations in Routine Therapeutic Drug Monitoring
- (2011) Arwa Hassan et al. THERAPEUTIC DRUG MONITORING
- Pharmacokinetics of Sulfobutylether-Beta-Cyclodextrin and Voriconazole in Patients with End-Stage Renal Failure during Treatment with Two Hemodialysis Systems and Hemodiafiltration
- (2010) V. Hafner et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Therapeutic Drug Monitoring of Posaconazole in Hematology Patients: Experience with a New High-Performance Liquid Chromatography-Based Method
- (2010) W. C. Neubauer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Melanoma Associated With Long-term Voriconazole Therapy
- (2010) Daniel D. Miller et al. ARCHIVES OF DERMATOLOGY
- Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: an European Organisation for Research and Treatment of Cancer study
- (2010) R Herbrecht et al. BONE MARROW TRANSPLANTATION
- Clinical importance of the CYP2C19*17 variant allele for voriconazole
- (2010) Michael J. Dolton et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Phase 1 pharmacokinetic and drug-interaction study of dasatinib in patients with advanced solid tumors
- (2010) Faye M. Johnson et al. CANCER
- Rifampin and Posaconazole Coadministration Leads to Decreased Serum Posaconazole Concentrations
- (2010) Carina Hohmann et al. CLINICAL INFECTIOUS DISEASES
- Exposure–Response of Posaconazole Used for Prophylaxis Against Invasive Fungal Infections: Evaluating the Need to Adjust Doses Based on Drug Concentrations in Plasma
- (2010) S H Jang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Effect of the CYP3A inhibitor ketoconazole on the pharmacokinetics and pharmacodynamics of bortezomib in patients with advanced solid tumors: A prospective, multicenter, open-label, randomized, two-way crossover drug—drug interaction study
- (2010) Karthik Venkatakrishnan et al. CLINICAL THERAPEUTICS
- Investigation into UDP-Glucuronosyltransferase (UGT) Enzyme Kinetics of Imidazole- and Triazole-Containing Antifungal Drugs in Human Liver Microsomes and Recombinant UGT Enzymes
- (2010) K. Bourcier et al. DRUG METABOLISM AND DISPOSITION
- Echinocandin Antifungal Drugs in Fungal Infections
- (2010) Sharon C.-A. Chen et al. DRUGS
- Effect of cytochrome P450 2C19 genotype on voriconazole exposure in cystic fibrosis lung transplant patients
- (2010) Maud Berge et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Effects of Rifampin and Ketoconazole on the Pharmacokinetics of Nilotinib in Healthy Participants
- (2010) Chiaki Tanaka et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Drug Interaction Between Itraconazole and Bortezomib: Exacerbation of Peripheral Neuropathy and Thrombocytopenia Induced by Bortezomib
- (2010) Takuya Iwamoto et al. PHARMACOTHERAPY
- Management of Drug and Food Interactions with Azole Antifungal Agents in Transplant Recipients
- (2010) Elizabeth Dodds-Ashley PHARMACOTHERAPY
- Periostitis Secondary to Prolonged Voriconazole Therapy in Lung Transplant Recipients
- (2009) T. F. Wang et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Accelerated Metabolism of Voriconazole and Its Partial Reversal by Cimetidine
- (2009) B. Moriyama et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Therapeutic Drug Monitoring of Posaconazole: a Monocentric Study with 54 Adults
- (2009) D. Lebeaux et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Drug interaction between voriconazole and calcineurin inhibitors in allogeneic hematopoietic stem cell transplant recipients
- (2009) T Mori et al. BONE MARROW TRANSPLANTATION
- Pharmacokinetics, metabolism and bioavailability of the triazole antifungal agent voriconazole in relation to CYP2C19 genotype
- (2009) Ina Scholz et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacogenetics of CYP2C19: functional and clinical implications of a new variant CYP2C19*17
- (2009) Alain Li-Wan-Po et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Omeprazole Significantly Reduces Posaconazole Serum Trough Level
- (2009) Jan‐Willem C. Alffenaar et al. CLINICAL INFECTIOUS DISEASES
- Voriconazole Pharmacokinetics and Pharmacodynamics in Children
- (2009) Michael Neely et al. CLINICAL INFECTIOUS DISEASES
- Voriconazole concentrations and outcome of invasive fungal infections
- (2009) S. Miyakis et al. CLINICAL MICROBIOLOGY AND INFECTION
- Effects of oral posaconazole on the pharmacokinetics of sirolimus
- (2009) Allen Moton et al. CURRENT MEDICAL RESEARCH AND OPINION
- Pediatric antifungal agents
- (2009) Michael Cohen-Wolkowiez et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Anidulafungin, a New Echinocandin
- (2009) Francesco Menichetti DRUGS
- Monitoring trough concentration of voriconazole is important to ensure successful antifungal therapy and to avoid hepatic damage in patients with hematological disorders
- (2009) Koki Ueda et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Safety of triazole antifungal drugs in patients with cancer
- (2009) S. Cronin et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Pharmacokinetics and safety of 14 days intravenous voriconazole in allogeneic haematopoietic stem cell transplant recipients
- (2009) R. J. M. Bruggemann et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Assessment of CYP2C19 genetic polymorphisms in a korean population using a simultaneous multiplex pyrosequencing method to simultaneously detect the CYP2C19*2, CYP2C19*3, and CYP2C19*17 alleles
- (2009) K.-A. Kim et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Chronic phototoxicity and aggressive squamous cell carcinoma of the skin in children and adults during treatment with voriconazole
- (2009) Edward W. Cowen et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Pharmacokinetics and Absorption of Posaconazole Oral Suspension under Various Gastric Conditions in Healthy Volunteers
- (2008) G. Krishna et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population Pharmacokinetic Analysis of Voriconazole Plasma Concentration Data from Pediatric Studies
- (2008) M. O. Karlsson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comprehensive In Vitro Analysis of Voriconazole Inhibition of Eight Cytochrome P450 (CYP) Enzymes: Major Effect on CYPs 2B6, 2C9, 2C19, and 3A
- (2008) S. Jeong et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Limited frequency of the CYP2C19*17 allele and its minor role in a Japanese population
- (2008) Katsuyoshi Sugimoto et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Hallucinations during Voriconazole Therapy
- (2008) Dimitrios I. Zonios et al. CLINICAL INFECTIOUS DISEASES
- Pharmacokinetics/Genotype Associations for Major Cytochrome P450 Enzymes in Native and First- and Third-generation Japanese Populations: Comparison With Korean, Chinese, and Caucasian Populations
- (2008) SP Myrand et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The CYP2C19 ultra-rapid metabolizer genotype influences the pharmacokinetics of voriconazole in healthy male volunteers
- (2008) Guo Wang et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Diagnostic and therapeutic approach to persistent or recurrent fevers of unknown origin in adult stem cell transplantation and haematological malignancy
- (2008) C. O. Morrissey et al. INTERNAL MEDICINE JOURNAL
- Optimizing antifungal drug dosing and monitoring to avoid toxicity and improve outcomes in patients with haematological disorders
- (2008) L. J. Worth et al. INTERNAL MEDICINE JOURNAL
- CYP2C19Genotype Is a Major Factor Contributing to the Highly Variable Pharmacokinetics of Voriconazole
- (2008) Johanna Weiss et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Concurrent Administration of Sirolimus and Voriconazole: A Pilot Study Assessing Safety and Approaches to Appropriate Management
- (2008) Dorothy Surowiec et al. PHARMACOTHERAPY
- Pharmacokinetics of Oral Posaconazole in Neutropenic Patients Receiving Chemotherapy for Acute Myelogenous Leukemia or Myelodysplastic Syndrome
- (2008) Gopal Krishna et al. PHARMACOTHERAPY
- Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes
- (2007) A. Pascual et al. CLINICAL INFECTIOUS DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now